Stanback
- Product NDC
- 63029-501
- 11-digit product format
- 630290501
- Labeler code
- 63029
- Product ID
- 63029-501_c7af9f6c-018c-4612-b0a6-ba2e90fbec37
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Aspirin and Caffeine
- Dosage form
- POWDER
- Route
- ORAL
- Labeler
- Medtech Products Inc.
- Application
- M013
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2012-10-01
- Substance
- ASPIRIN; CAFFEINE
- Active strength
- 845; 65 mg/1; mg/1
- Pharmacologic classes
- Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [EPC], Nonsteroidal Anti-inflammatory Drug [EPC], Platelet Aggregation Inhibitor [EPC], Xanthines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Stanback
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ASPIRIN | 845 mg/1 |
| CAFFEINE | 65 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | R16CO5Y76E, 3G6A5W338E |
| Rxcui | 994435, 1053327 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63029-501-01 | 2020-04-23 | C162847 | 48780-1 | 9d75b9cf-d2bc-f424-e053-dadaa90a57ce | Stanback |
| 63029-501-02 | 2020-04-23 | C162847 | 48780-1 | 9d75b9cf-d2bc-f424-e053-dadaa90a57ce | Stanback |
| 63029-501-06 | 2020-04-23 | C162847 | 48780-1 | 9d75b9cf-d2bc-f424-e053-dadaa90a57ce | Stanback |
| 63029-501-24 | 2020-04-23 | C162847 | 48780-1 | 9d75b9cf-d2bc-f424-e053-dadaa90a57ce | Stanback |
| 63029-501-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d2bc-f424-e053-dadaa90a57ce | Stanback |
| 63029-501-02 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d2bc-f424-e053-dadaa90a57ce | Stanback |
| 63029-501-06 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d2bc-f424-e053-dadaa90a57ce | Stanback |
| 63029-501-24 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d2bc-f424-e053-dadaa90a57ce | Stanback |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63029-501-01 | Stanback | 50 in 1 CARTON | POWDER | 50 | 12 | |
| 63029-501-02 | Stanback | 2 in 1 PACKAGE | POWDER | 2 | 12 | |
| 63029-501-06 | Stanback | 6 in 1 PACKAGE | POWDER | 6 | 12 | |
| 63029-501-24 | Stanback | 24 in 1 CARTON | POWDER | 24 | 12 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63029-501-01 | EA - Each | 63029-501 | 1a6a8f40-6b56-4858-b452-bcdc4963344a | 1 | 2022-06-06 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ASPIRIN | ACTIVE INGREDIENT | R16CO5Y76E | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| CAFFEINE | ACTIVE INGREDIENT | 3G6A5W338E | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| ASPIRIN | ACTIVE MOIETY | R16CO5Y76E | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| CAFFEINE | ACTIVE MOIETY | 3G6A5W338E | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| DOCUSATE SODIUM | INACTIVE INGREDIENT | F05Q2T2JA0 | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| FUMARIC ACID | INACTIVE INGREDIENT | 88XHZ13131 | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 | |
| POTASSIUM CHLORIDE | INACTIVE INGREDIENT | 660YQ98I10 | STANBACK (ASPIRIN AND CAFFEINE) POWDER [MEDTECH PRODUCTS INC.] | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 994435 | aspirin 845 MG / caffeine 65 MG Oral Powder | PSN | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 1053327 | STANBACK Headache Powder 845 MG / 65 MG Oral Powder, Reformulated Jan 2011 | PSN | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 1053327 | aspirin 845 MG / caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011] | SBD | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 994435 | aspirin 845 MG / caffeine 65 MG Oral Powder | SCD | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 994435 | ASA 845 MG / Caffeine 65 MG Oral Powder | SY | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 1053327 | ASA 845 MG / Caffeine 65 MG Oral Powder [Stanback Headache Powder Reformulated Jan 2011] | SY | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
| 1053327 | Stanback Headache Powder Reformulated Jan 2011 (ASA 845 MG / caffeine 65 MG) Oral Powder | SY | caaa1313-09e4-45aa-8836-346f6a370196 | 12 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63029-501-01 | 63029050101 | 50 POWDER in 1 CARTON (63029-501-01) | 50 powder | 2012-10-01 | 0000-00-00 | No | No | Current |
| 63029-501-02 | 63029050102 | 2 POWDER in 1 PACKAGE (63029-501-02) | 2 powder | 2012-10-01 | 0000-00-00 | No | No | Current |
| 63029-501-06 | 63029050106 | 6 POWDER in 1 PACKAGE (63029-501-06) | 6 powder | 2012-10-01 | 0000-00-00 | No | No | Current |
| 63029-501-24 | 63029050124 | 24 POWDER in 1 CARTON (63029-501-24) | 24 powder | 2012-06-01 | 0000-00-00 | No | No | Current |